ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
26 May 2020 17:37

A Block Deal Placement (348 Billion Won) Of Celltrion Healthcare by One Equity Partners

After the market close today, it was announced that One Equity Partners private equity firm will sell 348 billion won worth of Celltrion Healthcare...

Logo
333 Views
Share
26 May 2020 16:56

Celltrion Healthcare Placement: Past Performance Bodes Well for Sell-Down Before Lockup Expiry

One Equity Partners is looking to sell 4 m shares in Celltrion Healthcare (091990 KS). Post-placement, One Equity Partners will still have about a...

Logo
282 Views
Share
13 Apr 2020 09:17

Celltrion Healthcare Macro Bull Energy to Test 2018 Highs

Celltrion Healthcare (091990 KS) shows clear risk support to work with for a stop, setting the stage to buy weakness with the summer 2018 highs...

Share
08 Apr 2020 07:10

Big Short Covering on Celltrion Inc & Celltrion Healthcare

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 3 April 2020, the...

Logo
380 Views
Share
07 Apr 2020 03:45

Celltrion Healthcare Block Deals: Conditions, Discount, Overhang, & Arb Yield

It is now clear that neither OEP or Ion (Temasek) wants to stay at Celltrion as a long-term investor. Celltrion management reportedly asked OEP...

Logo
364 Views
Share
x